Nephroquiz 2: differential diagnoses of mesangial proliferative glomerulonephritis.

نویسندگان

  • Mahmoud Parvin
  • Farshid Haghverdi
  • Pedram Ahmadpoor
چکیده

CASE A 38-year-old man was admitted to hospital for evaluation of kidney dysfunction. His serum creatinine on admission was 1.6 mg/dL. His past medical history was unremarkable and there was no family history of kidney dysfunction. His blood pressure was 130/80 mm Hg, and he had no history of hypertension. Physical examination revealed only mild pedal edema. On urinalysis, there were microscopic hematuria with dysmorphic erythrocytes and proteinuria. Twenty-four-hour urine collection revealed 1200-mg protein excretion per day. Studies of serum complements, antinuclear antibodies, antineutrophil cytoplasmic antibodies, rheumatoid factor, and hepatitis viral markers had unremarkable results. The size of the kidneys was normal on ultrasonography. Biopsy of the kidney was performed, and light microscopic study of the tissue revealed 10 glomeruli all of which showing mesangial widening with hypercellularity. No obvious endocapillary proliferation or subendothelial deposits were identified (Figure 1). The immunofluorescence study revealed deposition of immunoglobulin A (IgA) and complement 3 (C3) in the mesangial regions (Figure 2). Based on pathologic findings, a diagnosis of mesangiopathic glomerulonephritis with IgA deposition, consistent with IgA nephropathy class III, was established. IJKD 2009;3:172-3 www.ijkd.org

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).

We report a case of mesangial proliferative glomerulonephritis with interstitial nephritis associated with multicentric Castleman's disease (MCD) successfully treated with an anti-interleukin-6 receptor antibody (tocilizumab). This mesangial proliferative glomerulonephritis with interstitial nephritis was resistant to methylprednisolone treatment; however, it was markedly improved with tocilizu...

متن کامل

Stimulation of Soluble Guanylyl Cyclase (sGC) Inhibits Mesangial Cell Proliferation and Matrix Accumulation in Experimental Glomerulonephritis

Background: To date no specific treatment is established in mesangial proliferative glomerulonephritis in man. Specific stimulation of soluble guanylyl cyclase (sGC), an enzyme catalyzing the synthesis of cyclic GMP from GTP, can be achieved by the novel pyrazolopyridine derivative Bay 41-2272. In this study, we investigated the effects of sGC stimulation in experimental mesangial proliferative...

متن کامل

Steroid-responsive nephrotic syndrome in a patient with proliferative glomerulonephritis with monoclonal IgG deposits with pure mesangial proliferative features

A 78-year-old woman developed acute-onset nephrotic syndrome. A renal biopsy showed mild mesangial proliferative glomerulonephritis. Immunofluorescence studies revealed granular IgG3- λ deposits within the mesangial area and along the glomerular capillary walls. Electron microscopy showed mesangial and subendothelial granular electron-dense deposits. The pattern of deposition was predominantly ...

متن کامل

PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.

BACKGROUND Matrix expansion and mesangial proliferation are hallmarks of mesangial proliferative glomerulonephritis. Specific inhibition of PDE-5, an enzyme catalyzing the intracellular degradation of cyclic GMP, can be achieved by the inhibitor vardenafil. In this study, we investigated the effects of PDE-5 inhibition in the anti-Thy1 model in the rat in vivo. METHODS After disease induction...

متن کامل

Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.

To date, no specific treatment is established in mesangial proliferative glomerulonephritis in humans. Specific stimulation of soluble guanylyl cyclase (sGC), an enzyme catalyzing the synthesis of cGMP from GTP, can be achieved by the novel pyrazolopyridine derivative BAY 41-2272. The effect of sGC stimulation via BAY 41-2272 on mesangial proliferation was assessed in vivo using a mesangial pro...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Iranian journal of kidney diseases

دوره 3 3  شماره 

صفحات  -

تاریخ انتشار 2009